Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $160.66 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vapotherm Inc | $32.05 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $30.05 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $28.75 | 2 | $0 (2023) |
| PFIZER INC. | $19.01 | 1 | $0 (2021) |
| Indivior Inc. | $17.86 | 1 | $0 (2023) |
| Novo Nordisk Inc | $17.58 | 1 | $0 (2020) |
| Biogen, Inc. | $15.36 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $31.90 | 2 | Indivior Inc. ($17.86) |
| 2022 | $14.71 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($14.71) |
| 2021 | $34.37 | 2 | PFIZER INC. ($19.01) |
| 2020 | $17.58 | 1 | Novo Nordisk Inc ($17.58) |
| 2018 | $62.10 | 2 | Vapotherm Inc ($32.05) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Gastroenterology | ||||||
| 08/08/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: BH | ||||||
| 04/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 07/07/2021 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROLOGY | ||||||
| 01/29/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: GASTROINTESTINAL | ||||||
| 09/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Diabetes | ||||||
| 10/09/2018 | Vapotherm Inc | Precision Flow (Device) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: Respiratory | ||||||
| 09/07/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,330 | 4,436 | $184,501 | $93,945 |
| 2022 | 21 | 2,710 | 4,857 | $174,570 | $93,465 |
| 2021 | 22 | 2,964 | 5,094 | $167,187 | $91,400 |
| 2020 | 23 | 3,373 | 6,116 | $199,580 | $103,867 |
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 560 | 1,775 | $106,500 | $63,115 | 59.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 23 | 208 | $19,760 | $5,546 | 28.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 185 | 186 | $4,969 | $4,682 | 94.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 391 | 573 | $22,920 | $4,330 | 18.9% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 154 | 155 | $3,255 | $3,150 | 96.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 367 | 571 | $2,855 | $2,764 | 96.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $2,380 | $2,332 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 31 | $2,238 | $2,183 | 97.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 41 | 46 | $1,380 | $1,352 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 23 | 37 | $1,850 | $1,137 | 61.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 30 | 70 | $2,800 | $849.32 | 30.3% |
| 87449 | Detection test by immunoassay technique for other organism | Office | 2023 | 44 | 52 | $1,560 | $610.48 | 39.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 110 | 157 | $1,884 | $609.54 | 32.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $960.00 | $328.30 | 34.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 16 | 65 | $1,300 | $261.94 | 20.1% |
| 82948 | Blood glucose (sugar) measurement using reagent strip | Office | 2023 | 48 | 52 | $520.00 | $256.67 | 49.4% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 45 | 50 | $3,750 | $169.60 | 4.5% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 181 | 312 | $3,120 | $93.84 | 3.0% |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | Office | 2023 | 20 | 32 | $320.00 | $87.94 | 27.5% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 15 | 18 | $180.00 | $85.09 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 631 | 1,879 | $102,020 | $62,385 | 61.1% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 26 | 208 | $16,880 | $6,441 | 38.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 444 | 633 | $19,170 | $4,828 | 25.2% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2022 | 184 | 190 | $3,980 | $3,731 | 93.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 216 | 222 | $3,774 | $3,702 | 98.1% |
About Dr. Willie Wells, MD
Dr. Willie Wells, MD is a Family Medicine healthcare provider based in Bruce, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1841315678.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Willie Wells, MD has received a total of $160.66 in payments from pharmaceutical and medical device companies, with $31.90 received in 2023. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($160.66).
As a Medicare-enrolled provider, Wells has provided services to 11,377 Medicare beneficiaries, totaling 20,503 services with total Medicare billing of $382,678. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bruce, MS
- Active Since 03/20/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841315678
Products in Payments
- Precision Flow (Device) $32.05
- XARELTO (Drug) $30.05
- XIFAXAN (Drug) $28.75
- COLOGUARD DNA CAPTURE REAGENTS (Device) $19.01
- PERSERIS (Drug) $17.86
- Ozempic (Drug) $17.58
- ADUHELM (Biological) $15.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.